Maria E. Elez
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancer.
Journal: The oncologist
Published: February 10, 2026
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer.
Journal: The oncologist
Published: May 08, 2025
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study.
Journal: ESMO gastrointestinal oncology
Published: February 01, 2024
Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer.
Journal: Journal for immunotherapy of cancer
Published: December 14, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers.
Journal: Journal for immunotherapy of cancer
Published: January 06, 2022
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: August 01, 2021
Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer.
Journal: Expert opinion on pharmacotherapy
Published: March 15, 2018
Current and advancing treatments for metastatic colorectal cancer.
Journal: Expert opinion on biological therapy
Published: November 10, 2015
A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 18, 2014
First-in-human phase I study of Lurbinectedin (PM01183) in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 25, 2014
A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 31, 2013
Phase II open-label study to assess efficacy and safety of lenalidomide in combination with cetuximab in KRAS-mutant metastatic colorectal cancer.
Journal: PloS one
Published: January 16, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026